Pharmacy Compounded Sterile Preparation (CSP) VISN 15
Veterans Affairs · 255-NETWORK CONTRACT OFFICE 15 (36C255)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25526R0023 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The VA Heartland Health Care Network (VISN 15) requires a VISN-wide contingency IDIQ Requirements contract for all medications, diluents, fluids, IV Tubing, closed system drug transfer devices and any other compounding and administration supplies items deemed necessary for the provision of hazardous and non-hazardous compounded intravenous products. (Attachment D. 1) The quantities reflected in Attachment D.1 is estimated annual requirements provided for pricing and planning purposes. These figures do not represent guaranteed purchase commitments. Actual quantities ordered under this VISN-wide… (show all)
contingency Requirements contract will vary based on patient-specific needs and operational requirements throughout the contract term. The government reserves the right to order more or fewer quantities than estimated. All sterile products will be aseptically compounded based on patient specific orders, in accordance with federal, state and local laws and any regulatory or accrediting bodies. Additionally, the vendor shall provide all deliveries and handling of materials and supplies to ensure appropriate storage conditions are maintained during shipment, to include segregated shipment and labeling for hazardous versus non-hazardous sterile compounds. Pricing in B.2 Price/Cost Schedule is all inclusive. Contractor shall provide and update the �VHA Pharmacy Benefits Management (PBM) Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies� at time of solicitation response and annually thereafter (See Attachment D. 2 VHA PBM)
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (255-NETWORK CONTRACT OFFICE 15 (36C255)), same NAICS 325412.
Single-winner award sizes (3): middle half $814K to $1.1M, median $892K; range $737K to $1.4M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $1.6M | Aug 21, 2026 |
| SOFIE Co. DULLES 20166 | 1 | $1.4M | Jan 12, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Aug 21, 2026Novartis Pharmaceuticals Corporation$892K6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063No listed company matched (Materiality N/A)
- Jan 12, 2026SOFIE Co. DULLES 20166$1.4M6505--36C25526D0024 PET/CT Doses - KC VAMCNo listed company matched (Materiality N/A)
- Aug 11, 2025Novartis Pharmaceuticals Corporation$737K6505--Pluvicto, STL 36C255-25-AP-0008No listed company matched (Materiality N/A)
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.